EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Copeptin kinetics in healthy aging

Sven Lustenberger iD, Friederike Riehle, Leyla Blattmann, Deborah R Vogt iD, Nania Schärer, Julie Refardt iD, Mirjam Christ-Crain iD

The Journal of Clinical Endocrinology & Metabolism · 13.08.2026 · 111 (9) · 2436-2444

DOI: 10.1210/clinem/dgag143 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 09.04.2026. Verfasst von Sven Lustenberger und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, 4031 Basel, Switzerland. Hauptthemen laut MEDLINE: Glycopeptides, Healthy Aging, Arginine Vasopressin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The risk for disturbances in water homeostasis—resulting in hypo- or hypernatremia—increases with age. Age-related changes in arginine vasopressin (AVP) kinetics have been suggested, but findings are inconclusive due to challenges in quantifying AVP. Copeptin is a stable surrogate marker for AVP secretion, yet no data on age-related changes of copeptin kinetics are available.

Objective

We investigated copeptin kinetics in healthy ageing, hypothesizing a reduced within-subject range of copeptin in older individuals.

Methods

For this randomized controlled cross-over trial, 16 healthy older adults aged ≥60 years and 16 healthy younger adults aged 18-30 years were recruited. Participants underwent 1 copeptin stimulation test (infusion of 10 mL/kg of 3% saline in 60 minutes) and 1 copeptin suppression test (ingestion of 20 mL/kg tap water in 60 minutes) in randomized order. During both tests, copeptin was measured at baseline and at 15, 30, 45, 60, and 120 minutes. The primary outcome was the within-subject copeptin range in older adults compared with younger controls.

Results

Median (interquartile range) age of older adults was 67 (64, 72) years and 26 (23, 28) years in younger controls. In both groups, 50% were female. The within-subject copeptin range in older adults was 12.6 (8.5, 18.7) pmol/L and comparable with that of younger controls with 14.2 (8.5, 16.6) pmol/L (P = .867). While the copeptin response to stimulation was comparable between groups (β = +3.9 [95% CI: −2.9, +10.7; P = .020] pmol·h/L for older adults), older adults exhibited a smaller decrease than younger controls during suppression (β = + .8 [95% CI: +0.3, +1.3; P = .005] pmol·h/L).

Conclusion

Copeptin kinetics are mostly preserved in healthy older adults, yet the ability to suppress copeptin after hydration is diminished. This may contribute to the higher prevalence of hyponatremia in older individuals and should be considered in future fluid intake guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycopeptidesHealthy AgingArginine VasopressinHumansFemaleAdultAgedYoung AdultCross-Over StudiesMiddle AgedMaleKineticsAdolescentBiomarkersAging

Stichwörter der Autor:innen

AVPRCTcopeptinhealthy agingvasopressin

Substanzen

GlycopeptidescopeptinsArginine VasopressinBiomarkers

Autor:innen und Institutionen

  • Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, 4031 Basel, Switzerland.
  • Department of Clinical Research, University of Basel, 4031 Basel, Switzerland.
  • Department of Internal Medicine, Erasmus Medical Center, 3015 Rotterdam, the Netherlands.

ORCID-Profile: Sven Lustenberger, Deborah R Vogt, Julie Refardt, Mirjam Christ-Crain

Förderung

  • Swiss National Science Foundation

Zitieren

APA

Lustenberger, S., Riehle, F., Blattmann, L., Vogt, D. R., Schärer, N., Refardt, J., & Christ-Crain, M. (2026). Copeptin kinetics in healthy aging. The Journal of Clinical Endocrinology & Metabolism, 111(9), 2436-2444. https://doi.org/10.1210/clinem/dgag143

Vancouver

Lustenberger S, Riehle F, Blattmann L, Vogt DR, Schärer N, Refardt J, et al. Copeptin kinetics in healthy aging. The Journal of Clinical Endocrinology & Metabolism. 2026;111(9):2436-2444. doi:10.1210/clinem/dgag143

BibTeX
@article{Lustenberger2026,
  author = {Lustenberger, Sven and Riehle, Friederike and Blattmann, Leyla and Vogt, Deborah R and Schärer, Nania and Refardt, Julie and Christ-Crain, Mirjam},
  title = {Copeptin kinetics in healthy aging},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  volume = {111},
  number = {9},
  pages = {2436--2444},
  doi = {10.1210/clinem/dgag143}
}
Kostenlos starten →